PathAI

PathAI

AI-powered pathology platform for diagnostics

About

PathAI focuses on enhancing patient outcomes by using an AI-powered pathology platform. This platform improves the accuracy of medical diagnoses and the effectiveness of treatments for diseases like cancer through advanced machine learning techniques. PathAI provides diagnostic tools and services to healthcare providers, research institutions, and pharmaceutical companies, generating revenue through partnerships, licensing, and service fees. What sets PathAI apart from its competitors is its commitment to solving complex healthcare problems with a diverse team and a focus on making a significant impact in the medical field. The company's goal is to improve the overall quality of patient care by ensuring more accurate diagnoses and better treatment options.

Company Stage

Debt Financing

Employees

201-500

Industries

AI & Machine Learning, Healthcare

Total Funding

$251.6M

Headquarters

Boston, Massachusetts

Founded

2016


Simplify Jobs

Simplify's Take

What believers are saying

  • PathAI's collaboration with Quest Diagnostics positions it to accelerate AI adoption in pathology, potentially leading to significant advancements in cancer diagnosis.
  • The unveiling of new AI-powered pathology tools like PathExplore and IHC Explore1 highlights PathAI's continuous innovation and leadership in the field.
  • The company's focus on expanding its AI technology and software business could lead to increased market share and revenue growth.

What critics are saying

  • The integration of PathAI's technology with Quest Diagnostics' operations may face challenges, potentially affecting the efficiency of AI adoption.
  • The competitive landscape in AI-powered pathology is intensifying, which could impact PathAI's market position and growth.

What makes PathAI unique

  • PathAI's focus on AI-powered pathology tools, such as PathExplore and AISight, sets it apart in the digital pathology space by offering advanced diagnostic capabilities.
  • The company's strategic partnerships, like the one with Quest Diagnostics, enhance its AI algorithm development and expand its reach in the biopharma sector.
  • PathAI's early access programs for AISight in both the U.S. and Europe demonstrate its commitment to democratizing digital pathology and improving patient outcomes globally.

Help us improve and share your feedback! Did you find this helpful?


Growth & Insights
Headcount

6 month growth

-7%

1 year growth

-7%

2 year growth

-21%

Benefits

Competitive medical, dental, and vision insurance

Retirement plan options

Paid parental leave

Health & wellness benefits

Flexible work options

Generous paid time off

Recently Posted Jobs

Sign up to get curated job recommendations

PathAI is Hiring for 0 Jobs on Simplify!

Find jobs on Simplify and start your career today

💡
We update PathAI's jobs every 8 hours, so check again soon! Browse all jobs →